Alzheimer’s is at a turning point in Europe. As new treatments emerge, the real challenge is no longer just innovation, but ensuring patients can access them in time.
This policy breakfast will bring together EU policymakers, healthcare experts, patient representatives, and industry leaders to explore how Europe can turn scientific progress into real-world impact. The discussion will focus on overcoming regulatory, reimbursement, and system barriers that risk delaying access, and on identifying concrete policy actions to ensure Europe remains competitive while delivering timely, equitable care for patients.
This event is by invitation only.
Interested in this event?
Share This Event
